Related Experiment Videos
Phlegmonous gastritis associated with HIV-1 seroconversion. Endoscopic and microscopic evolution
J F Zazzo1, G Troché, B Millat
1Department of Anesthesiology, Hôpital Antoine Béclère, Université Paris-Sud, Clamart, France.
Digestive Diseases and Sciences
|September 1, 1992
Summary
Phlegmonous gastritis, a rare condition, was diagnosed via laparotomy in a patient with peritonitis. Prompt treatment with antibiotics and conservative measures led to successful recovery, highlighting the importance of early intervention for this potentially fatal disease.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Surgical Pathology
Background:
- Phlegmonous gastritis is a rare and severe form of gastritis characterized by diffuse inflammation and edema of the gastric wall.
- Early diagnosis and intervention are crucial for improving patient outcomes in cases of phlegmonous gastritis.
- The presentation of phlegmonous gastritis can mimic other acute abdominal conditions, posing diagnostic challenges.
Observation:
- A 40-year-old male presented with symptoms of peritonitis, necessitating a diagnostic laparotomy.
- During the hospital stay, the patient was found to have seroconversion to Human Immunodeficiency Virus type 1 (HIV-1).
- The case involved multiple endoscopic procedures with biopsies, providing insights into the disease's progression.
Findings:
- Laparotomy confirmed the diagnosis of phlegmonous gastritis.
- A treatment regimen combining conservative management and antibiotics proved effective in resolving the condition.
- The patient's concurrent HIV-1 seroconversion added complexity to the clinical picture.
Implications:
- This case underscores the importance of prompt diagnosis and appropriate treatment for phlegmonous gastritis, a condition with a historically high mortality rate.
- The successful conservative and antibiotic management suggests a potentially favorable prognosis when intervention is timely.
- The occurrence of HIV-1 seroconversion during hospitalization highlights the need for vigilance regarding opportunistic infections in critically ill patients.